期刊文献+

地塞米松眼用微乳的研究 被引量:22

Preparation of Dexamethasone Microemulsion for Ocular Application
在线阅读 下载PDF
导出
摘要 目的以微乳为载体,制备适合眼部用药的地塞米松滴眼液。方法选择适宜的油、表面活性剂和助表面活性剂,以离心稳定性和乳滴粒径为评价标准,优化处方和工艺。通过影响因素试验初步评价地塞米松眼用微乳的稳定性,并通过家兔眼刺激性实验评价了地塞米松眼用微乳的安全性。结果地塞米松眼用微乳的乳滴平均粒径为36.8 nm,经离心(13 000 r.min-1,30 min)稳定,高温、强光条件下考察10 d,乳滴粒径、pH值和含量均未见显著变化,对家兔的眼部组织无刺激性。结论微乳作为热力学稳定系统,制备工艺简单,生物相容性好,适合作为眼部用药的载体。 OBJECTIVE To prepare dexamethasone microemulsion for topical ocular chug delivery. METHODS Centrifuge test and the average diameter of droplet were used as the criterion to optimize the formulation and process. The optimized preparation was obtained and put into the condition of high temperature(60 ℃) or strong light(4 500 ± 500)lx for 10 d to observe its stability. Ocular irritation test was performed in rabbits to evaluate the safety of the dexamethasone mlicroemulsion.RESULTS Dexamethasone microemulsion for ocular appilication was stable. The average diameter of droplet was 36.8 nm. The ocular irritation test suggested that the microemulsion was sale to c.ornea, conjunctiva and iris. CONCLUSION Microcmulsions are suitable vehicles for ocular drug delivery systems, owing to their stability, simple process and low-toxicity.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第5期358-362,共5页 Chinese Pharmaceutical Journal
关键词 地塞米松 微乳 稳定性 眼刺激性 dexamethasone microemulsion stability ocular irritation
  • 相关文献

参考文献8

  • 1RADOMSKA A,DOKRUCKI R.The use of some ingredients for microemulsion preparation containing retinal and its esters[J].Int J Pharm,2000,196(2):131-134.
  • 2VANDAMME T H F.Microemulsions as ocular drug delivery systems:recent developments and future challenges[J].Prog Retin Eye Res,2002,21 (1):15-34.
  • 3吴顺芹,李三鸣,郎轶咏,刘华,刘洪卓.水包油型微乳形成因素的考察[J].沈阳药科大学学报,2005,22(2):96-99. 被引量:21
  • 4朱林,朱家壁,屠颖,田煦.全反式维A酸磷脂混合胶团注射剂的制备[J].药学学报,2004,39(3):220-222. 被引量:2
  • 5LUB.New Tecniques and New Dosage Forms of Drugs(药物新剂型与新技术)[M].Beijing:People' s Medical Publishing House,1998:93-94.
  • 6HASSE A,KEIPERT S.Development and characterization of microemulsions for ocular application[J].Eur J Pharm Biopharm,1997,43 (2):179-183.
  • 7SHAUL M,MUHAMAD A,JOSEPH F,et al.Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea[J].J Controlled Release,1997,44(1):55-64.
  • 8SFDA.Guidance for the irritation,hepersensitivity and hemolytic testing of generic chemical medicine(化学药物刺激性、过敏性和溶血性研究技术指导原则)[EB/OL].http://www.sda.gov.cn/gsz05106/14.pdf.2005-03-18.

二级参考文献5

  • 1崔正刚 殷福珊.微乳化技术与应用[M].北京:中国轻工业出版社,1999..
  • 2Lawrence MJ, Gareth DR. Microemulsion-based media as novel drug delivery systems [ J ]. Adv Drug Delivery Rev, 2000, 45(1) :89 - 121.
  • 3Warisnoicharoen W, Lansley AB, Lawrence M J. Nonionic oil-in-water micro-emulsions: the effect of oil type on phase behaviour [ J ]. Int J Pharm, 2000, 198 ( 1 ) :7 - 27.
  • 4Aboofazeli R, Lawrence CB, Wicks SR, et al. Investigations into formation and characterization of phospholipid mieroemulsions. Ⅲ. Pseuo-temary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an alkanoic acid, amine, alkanediol, polyethylene glycol alkyl ether or alcohol as cosurfactant [J]. Int J Pharm, 1994, 111(1) :63 - 72.
  • 5赵蓉,朱家壁.全反式维甲酸立体稳定脂质体的制备[J].药学学报,2000,35(12):921-923. 被引量:9

共引文献21

同被引文献240

引证文献22

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部